• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同类型排斥反应受者血常规及外周血淋巴细胞亚群特征性变化

Characteristic changes in blood routine and peripheral blood lymphocyte subpopulations in recipients of different types of rejection.

机构信息

Department of Kidney Transplantation, Second Xiangya Hospital, Central South University, Changsha 410011.

Clinical Research Center for Organ Transplantation in Hunan Province, Second Xiangya Hospital, Central South University, Changsha 410011.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 28;49(3):417-425. doi: 10.11817/j.issn.1672-7347.2024.230543.

DOI:10.11817/j.issn.1672-7347.2024.230543
PMID:38970516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11208394/
Abstract

OBJECTIVES

Rejection remains the most important factor limiting the survival of transplanted kidneys. Although a pathological biopsy of the transplanted kidney is the gold standard for diagnosing rejection, its limitations prevent it from being used as a routine monitoring method. Recently, peripheral blood lymphocyte subpopulation testing has become an important means of assessing the body's immune system, however, its application value and strategy in the field of kidney transplantation need further exploration. Additionally, the development and utilization of routine test parameters are also important methods for exploring diagnostic strategies and predictive models for kidney transplant diseases. This study aims to explore the correlation between peripheral blood lymphocyte subpopulations and T cell-mediated rejection (TCMR) and antibody-mediated rejection (ABMR), as well as their diagnostic value, in conjunction with routine blood tests.

METHODS

A total of 154 kidney transplant recipients, who met the inclusion and exclusion criteria and were treated at the Second Xiangya Hospital of Central South University from January to December, 2021, were selected as the study subjects. They were assigned into a stable group, a TCMR group, and an ABMR group, based on the occurrence and type of rejection. The basic and clinical data of these recipients were retrospectively analyzed and compared among the 3 groups. The transplant kidney function, routine blood tests, and peripheral blood lymphocyte subpopulation data of the TCMR group and the ABMR group before rejection treatment were compared with those of the stable group.

RESULTS

The stable, TCMR group, and ABMR group showed no statistically significant differences in immunosuppressive maintenance regimens or sources of transplanted kidneys (all >0.05). However, the post-transplant duration was significantly longer in the ABMR group compared with the stable group (<0.001) and the TCMR group (<0.05). Regarding kidney function, serum creatinine levels in the ABMR group were higher than in the stable group and the TCMR group (both <0.01), with the TCMR group also showing higher levels than the stable group (<0.01). Both TCMR and ABMR groups had significantly higher blood urea nitrogen levels than the stable group (<0.01), with no statistically significant difference between TCMR and ABMR groups (>0.05). The estimated glomerular filtration rate (eGFR) was lower in both TCMR and ABMR groups compared with the stable group (both <0.01). In routine blood tests, the ABMR group had lower hemoglobin, red blood cell count, and platelet count than the stable group (all <0.05). The TCMR group had higher neutrophil percentage (<0.05) and count (<0.05) than the stable group, and the ABMR group had a higher neutrophil percentage than the stable group (<0.05). The eosinophil percentage and count in the TCMR group were lower than in the stable and ABMR groups (all <0.05). Both TCMR and ABMR groups had lower basophil percentage and count, as well as lower lymphocyte percentage and count, compared with the stable group (all <0.05). There were no significant differences in monocyte percentage and count among the 3 groups (all >0.05). In lymphocyte subpopulations, the TCMR and ABMR groups had lower counts of CD45 cells and T cells compared with the stable group (all <0.05). The TCMR group also had lower counts of CD4 T cells, NK cells, and B cells than the stable group (all <0.05). There were no significant differences in the T cell percentage, CD4 T cell percentage, CD8 T cell percentage and their counts, CD4/CD8 T cell ratio, NK cell percentage, and B cell percentage among the stable, TCMR, and ABMR groups (all >0.05).

CONCLUSIONS

The occurrence of rejection leads to impaired transplant kidney function, accompanied by characteristic changes in some parameters of routine blood tests and peripheral blood lymphocyte subpopulations in kidney transplant recipients. The different characteristics of changes in some parameters of routine blood tests and peripheral blood lymphocyte subpopulations during TCMR and ABMR may help predict and diagnose rejection and differentiate between TCMR and ABMR.

摘要

目的

排斥反应仍然是限制移植肾存活的最重要因素。虽然移植肾的病理活检是诊断排斥反应的金标准,但由于其局限性,不能作为常规监测方法。最近,外周血淋巴细胞亚群检测已成为评估机体免疫系统的重要手段,但在肾移植领域的应用价值和策略仍需进一步探索。此外,常规检测参数的开发和利用也是探索肾移植疾病诊断策略和预测模型的重要方法。本研究旨在探讨外周血淋巴细胞亚群与 T 细胞介导的排斥反应(TCMR)和抗体介导的排斥反应(ABMR)的相关性,并结合常规血液检查探讨其诊断价值。

方法

选取 2021 年 1 月至 12 月在中南大学湘雅二医院接受治疗的符合纳入和排除标准的 154 例肾移植受者为研究对象。根据排斥反应的发生和类型,将其分为稳定组、TCMR 组和 ABMR 组。回顾性分析比较 3 组受者的基本临床资料。比较 TCMR 组和 ABMR 组治疗前与稳定组的移植肾功能、常规血液检查和外周血淋巴细胞亚群数据。

结果

稳定组、TCMR 组和 ABMR 组的免疫抑制维持方案或移植肾来源无统计学差异(均>0.05)。然而,ABMR 组的移植后时间明显长于稳定组(<0.001)和 TCMR 组(<0.05)。在肾功能方面,ABMR 组的血清肌酐水平高于稳定组和 TCMR 组(均<0.01),而 TCMR 组也高于稳定组(<0.01)。TCMR 组和 ABMR 组的血尿素氮水平均明显高于稳定组(均<0.01),但两组之间无统计学差异(>0.05)。估算肾小球滤过率(eGFR)在 TCMR 组和 ABMR 组均低于稳定组(均<0.01)。在常规血液检查中,ABMR 组的血红蛋白、红细胞计数和血小板计数均低于稳定组(均<0.05)。TCMR 组的中性粒细胞百分比(<0.05)和计数(<0.05)高于稳定组,ABMR 组的中性粒细胞百分比高于稳定组(<0.05)。TCMR 组的嗜酸性粒细胞百分比和计数均低于稳定组和 ABMR 组(均<0.05)。TCMR 组和 ABMR 组的嗜碱性粒细胞百分比和计数以及淋巴细胞百分比和计数均低于稳定组(均<0.05)。三组间单核细胞百分比和计数无统计学差异(均>0.05)。在淋巴细胞亚群方面,TCMR 组和 ABMR 组的 CD45 细胞和 T 细胞计数均低于稳定组(均<0.05)。TCMR 组的 CD4 T 细胞、NK 细胞和 B 细胞计数也均低于稳定组(均<0.05)。稳定组、TCMR 组和 ABMR 组的 T 细胞百分比、CD4 T 细胞百分比、CD8 T 细胞百分比及其计数、CD4/CD8 T 细胞比值、NK 细胞百分比和 B 细胞百分比无统计学差异(均>0.05)。

结论

排斥反应的发生导致移植肾功能受损,同时伴有肾移植受者一些常规血液检查和外周血淋巴细胞亚群的特征性变化。TCMR 和 ABMR 时一些常规血液检查和外周血淋巴细胞亚群参数变化的不同特征,可能有助于预测和诊断排斥反应,并区分 TCMR 和 ABMR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/11208394/a9c5db2f8553/ZhongNanDaXueXueBaoYiXueBan-49-3-417-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/11208394/e2d3975c0982/ZhongNanDaXueXueBaoYiXueBan-49-3-417-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/11208394/a86bf43c2692/ZhongNanDaXueXueBaoYiXueBan-49-3-417-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/11208394/a9c5db2f8553/ZhongNanDaXueXueBaoYiXueBan-49-3-417-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/11208394/e2d3975c0982/ZhongNanDaXueXueBaoYiXueBan-49-3-417-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/11208394/a86bf43c2692/ZhongNanDaXueXueBaoYiXueBan-49-3-417-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eea/11208394/a9c5db2f8553/ZhongNanDaXueXueBaoYiXueBan-49-3-417-g003.jpg

相似文献

1
Characteristic changes in blood routine and peripheral blood lymphocyte subpopulations in recipients of different types of rejection.不同类型排斥反应受者血常规及外周血淋巴细胞亚群特征性变化
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Mar 28;49(3):417-425. doi: 10.11817/j.issn.1672-7347.2024.230543.
2
Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.晚期肾移植受者中,尽管存在持续的抗体介导排斥反应,但T细胞介导的排斥反应消失。
J Am Soc Nephrol. 2015 Jul;26(7):1711-20. doi: 10.1681/ASN.2014060588. Epub 2014 Nov 6.
3
T-cell Mediated Rejection Associated Microvascular Inflammation in the Allograft Kidney: RNAseq Analysis Using the Banff Human Organ Transplant Gene Panel.同种异体肾移植中 T 细胞介导的排斥反应相关微血管炎症:使用 Banff 人类器官移植基因谱的 RNAseq 分析。
Clin Transplant. 2024 Jul;38(7):e15410. doi: 10.1111/ctr.15410.
4
Long-term kidney allograft survival in patients with transplant glomerulitis.移植性肾小球炎患者长期肾移植存活率
Transplantation. 2015 Feb;99(2):331-9. doi: 10.1097/TP.0000000000000606.
5
Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.自然杀伤细胞浸润具有鉴别诊断抗体介导排斥反应的作用,并可预测肾移植后的结局。
Kidney Int. 2019 Jan;95(1):188-198. doi: 10.1016/j.kint.2018.08.027. Epub 2018 Nov 3.
6
Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.移植后1年的亚临床排斥反应表型与同种异体肾移植的结局
J Am Soc Nephrol. 2015 Jul;26(7):1721-31. doi: 10.1681/ASN.2014040399. Epub 2015 Jan 2.
7
Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samples.开发一种多变量基因表达特征,针对肾移植受者外周血中的 T 细胞介导的排斥反应,在横断面和纵向样本中得到验证。
EBioMedicine. 2019 Mar;41:571-583. doi: 10.1016/j.ebiom.2019.01.060. Epub 2019 Mar 2.
8
Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR.同种异体移植物抗宿主病(ABMR)中的自然杀伤(NK)细胞和移植物抗宿主病(TCMR)中的效应 T 细胞之间的机制共享。
Am J Transplant. 2018 Jan;18(1):63-73. doi: 10.1111/ajt.14410. Epub 2017 Aug 14.
9
The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.三因素研究:比较供体游离 DNA 水平与肾移植活检分子表型。
J Am Soc Nephrol. 2022 Feb;33(2):387-400. doi: 10.1681/ASN.2021091191. Epub 2022 Jan 20.
10
[Analysis of early changes in lymphocyte subpopulations after liver transplantation and their correlation with clinical manifestations].肝移植后淋巴细胞亚群早期变化及其与临床表现的相关性分析
Zhonghua Yu Fang Yi Xue Za Zhi. 2024 May 6;58(5):679-685. doi: 10.3760/cma.j.cn112150-20231120-00357.

引用本文的文献

1
Decoupled dynamics of absolute and relative lymphocyte counts and age-polarized CD4/CD8 ratio in infants versus older adults.婴儿与老年人中绝对和相对淋巴细胞计数的解耦动力学以及年龄极化的CD4/CD8比值
Front Immunol. 2025 Jul 24;16:1599515. doi: 10.3389/fimmu.2025.1599515. eCollection 2025.

本文引用的文献

1
Making human immune systems more interpretable through systems immunology.通过系统免疫学使人类免疫系统更具可解释性。
Trends Immunol. 2023 Aug;44(8):577-584. doi: 10.1016/j.it.2023.06.005. Epub 2023 Jul 3.
2
Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review.移植肾中的生物标志物开发蛋白质组学:更新综述。
Int J Mol Sci. 2023 Mar 9;24(6):5287. doi: 10.3390/ijms24065287.
3
Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant.鉴定血清和尿液细胞外囊泡特征,预测肾移植后肾脏结局。
Nephrol Dial Transplant. 2023 Feb 28;38(3):764-777. doi: 10.1093/ndt/gfac259.
4
Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm Study.肾移植术后早期输血不会导致 dnDSA 形成:BloodIm 研究。
Front Immunol. 2022 Mar 31;13:852079. doi: 10.3389/fimmu.2022.852079. eCollection 2022.
5
Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection.适应性免疫细胞反应作为抗体介导的器官排斥反应的治疗靶点。
Trends Mol Med. 2022 Mar;28(3):237-250. doi: 10.1016/j.molmed.2022.01.002. Epub 2022 Jan 29.
6
Time-dependent blood eosinophilia count increases the risk of kidney allograft rejection.时间依赖性血嗜酸性粒细胞计数增加肾移植排斥的风险。
EBioMedicine. 2021 Nov;73:103645. doi: 10.1016/j.ebiom.2021.103645. Epub 2021 Oct 20.
7
Lymphocyte function based on IFN-γ secretion assay may be a promising indicator for assessing different immune status in renal transplant recipients.基于 IFN-γ 分泌的淋巴细胞功能检测可能是评估肾移植受者不同免疫状态的有前途的指标。
Clin Chim Acta. 2021 Dec;523:247-259. doi: 10.1016/j.cca.2021.10.003. Epub 2021 Oct 7.
8
Monitoring of B Cell in Kidney Transplantation: Development of a Novel Clusters Analysis and Role of Transitional B Cells in Transplant Outcome.肾移植中B细胞的监测:一种新型聚类分析的发展及过渡性B细胞在移植结果中的作用
Diagnostics (Basel). 2021 Apr 1;11(4):641. doi: 10.3390/diagnostics11040641.
9
Exploring the Complexity of Death-Censored Kidney Allograft Failure.探索死亡相关的肾移植失败的复杂性。
J Am Soc Nephrol. 2021 Jun 1;32(6):1513-1526. doi: 10.1681/ASN.2020081215. Epub 2021 Apr 21.
10
Evaluation of Thymic Output and Regulatory T Cells in Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection.评估慢性抗体介导排斥反应的肾移植受者的胸腺输出和调节性 T 细胞。
Biomed Res Int. 2021 Feb 9;2021:6627909. doi: 10.1155/2021/6627909. eCollection 2021.